$CVS
CVS Health Corp

2018 Q4 Form 8-K Financial Statement

#000006480319000042 Filed on August 08, 2019

View on sec.gov

Income Statement

Concept 2018 Q4 2018 2017 Q4
Revenue $54.42B $194.6B $48.39B
YoY Change 12.47% 5.3% 5.26%
Cost Of Revenue $38.17B $156.4B $37.68B
YoY Change 1.28% 1.95% 4.01%
Gross Profit $16.74B $38.13B $10.72B
YoY Change 56.14% 21.68% 40.99%
Gross Profit Margin 30.77% 19.6% 22.16%
Selling, General & Admin $6.613B $21.37B $4.739B
YoY Change 39.54% 13.61% 3.86%
% of Gross Profit 39.49% 56.04% 44.19%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.718B
YoY Change 9.64%
% of Gross Profit 7.13%
Operating Expenses $13.21B $21.37B $7.549B
YoY Change 74.95% 13.61% 11.97%
Operating Profit $824.0M $4.021B $3.114B
YoY Change -73.54% -57.84% 3.97%
Interest Expense -$1.218B $2.619B -$318.0M
YoY Change 283.02% 146.61% 21.37%
% of Operating Profit -147.82% 65.13% -10.21%
Other Income/Expense, Net $11.00M $4.000M -$2.000M
YoY Change -650.0% -101.92% -60.0%
Pretax Income $102.0M $1.406B $2.809B
YoY Change -96.37% -82.99% 2.03%
Income Tax $624.0M $2.002B $1.022B
% Of Pretax Income 611.76% 142.39% 36.38%
Net Earnings -$419.0M -$594.0M $3.287B
YoY Change -112.75% -108.97% 92.56%
Net Earnings / Revenue -0.77% -0.31% 6.79%
Basic Earnings Per Share -$0.37 -$0.57 $3.23
Diluted Earnings Per Share -$0.37 -$0.57 $3.22
COMMON SHARES
Basic Shares Outstanding 1.044B shares
Diluted Shares Outstanding 1.044B shares

Balance Sheet

Concept 2018 Q4 2018 2017 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.418B $6.581B $1.807B
YoY Change 255.17% 264.19% -47.74%
Cash & Equivalents $4.059B $4.059B $1.696B
Short-Term Investments $2.359B $2.522B $111.0M
Other Short-Term Assets $4.581B $4.581B $945.0M
YoY Change 384.76% 384.76% 43.18%
Inventory $16.45B $16.45B $15.30B
Prepaid Expenses
Receivables $17.63B $17.63B $13.18B
Other Receivables $1.560B $0.00 $146.0M
Total Short-Term Assets $45.24B $45.24B $31.23B
YoY Change 44.87% 44.87% 0.6%
LONG-TERM ASSETS
Property, Plant & Equipment $11.35B $11.35B $10.29B
YoY Change 10.27% 10.27% 1.15%
Goodwill $78.68B $38.45B
YoY Change 104.62% 0.53%
Intangibles $36.52B $13.63B
YoY Change 167.97% 0.88%
Long-Term Investments $15.73B $15.73B
YoY Change
Other Assets $5.046B $8.930B $1.417B
YoY Change 256.1% 484.04% -4.58%
Total Long-Term Assets $151.2B $151.2B $63.90B
YoY Change 136.63% 136.63% 0.76%
TOTAL ASSETS
Total Short-Term Assets $45.24B $45.24B $31.23B
Total Long-Term Assets $151.2B $151.2B $63.90B
Total Assets $196.5B $196.5B $95.13B
YoY Change 106.51% 106.51% 0.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $26.44B $26.44B $19.22B
YoY Change 37.56% 37.56% 141.86%
Accrued Expenses $10.71B $10.71B $6.581B
YoY Change 62.76% 62.07% -5.13%
Deferred Revenue $67.00M $53.00M
YoY Change 26.42%
Short-Term Debt $720.0M $720.0M $1.276B
YoY Change -43.57% -43.57% -31.91%
Long-Term Debt Due $1.265B $1.265B $3.545B
YoY Change -64.32% -64.32% 8340.48%
Total Short-Term Liabilities $44.01B $44.01B $30.65B
YoY Change 43.6% 43.6% 16.75%
LONG-TERM LIABILITIES
Long-Term Debt $71.44B $71.44B $22.18B
YoY Change 222.1% 222.1% -13.41%
Other Long-Term Liabilities $2.780B $14.78B $1.277B
YoY Change 117.7% 817.63% -17.56%
Total Long-Term Liabilities $74.22B $86.23B $23.46B
YoY Change 216.41% 262.42% -13.64%
TOTAL LIABILITIES
Total Short-Term Liabilities $44.01B $44.01B $30.65B
Total Long-Term Liabilities $74.22B $86.23B $23.46B
Total Liabilities $137.9B $138.2B $57.44B
YoY Change 140.12% 140.65% 7.53%
SHAREHOLDERS EQUITY
Retained Earnings $40.91B $43.56B
YoY Change -6.07% 11.73%
Common Stock $17.00M $17.00M
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $28.23B $37.80B
YoY Change -25.31% 12.99%
Treasury Stock Shares 425.0M shares 698.0M shares
Shareholders Equity $58.23B $58.23B $37.69B
YoY Change
Total Liabilities & Shareholders Equity $196.5B $196.5B $95.13B
YoY Change 106.51% 106.51% 0.71%

Cashflow Statement

Concept 2018 Q4 2018 2017 Q4
OPERATING ACTIVITIES
Net Income -$419.0M -$594.0M $3.287B
YoY Change -112.75% -108.97% 92.56%
Depreciation, Depletion And Amortization $2.718B
YoY Change 9.64%
Cash From Operating Activities $2.479B $8.865B -$136.0M
YoY Change -1922.79% 10.72% -106.41%
INVESTING ACTIVITIES
Capital Expenditures -$585.0M $2.037B -$506.0M
YoY Change 15.61% 6.2% -17.99%
Acquisitions $42.23B
YoY Change 3475.44%
Other Investing Activities -$41.31B -$21.00M -$804.0M
YoY Change 5038.56% -36.36% 300.0%
Cash From Investing Activities -$41.90B -$43.29B -$1.310B
YoY Change 3098.4% 1404.52% 60.15%
FINANCING ACTIVITIES
Cash Dividend Paid $2.038B
YoY Change -0.54%
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net $5.522B
YoY Change
Cash From Financing Activities 1.892B $36.82B 670.0M
YoY Change 182.39% -645.39% -653.72%
NET CHANGE
Cash From Operating Activities 2.479B $8.865B -136.0M
Cash From Investing Activities -41.90B -$43.29B -1.310B
Cash From Financing Activities 1.892B $36.82B 670.0M
Net Change In Cash -37.53B $2.395B -776.0M
YoY Change 4736.08% -247.84% -165.65%
FREE CASH FLOW
Cash From Operating Activities $2.479B $8.865B -$136.0M
Capital Expenditures -$585.0M $2.037B -$506.0M
Free Cash Flow $3.064B $6.828B $370.0M
YoY Change 728.11% 12.14% -86.49%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q1 cvs Four Years Reinsurance Agreement With Unrelated Insurer
FourYearsReinsuranceAgreementWithUnrelatedInsurer
P4Y
CY2017 cvs Proceeds From Variable Interest Entity
ProceedsFromVariableInterestEntity
183000000 USD
CY2016Q4 cvs Treasury Stock Shares Heldin Trust
TreasuryStockSharesHeldinTrust
1000000 shares
CY2017Q4 cvs Treasury Stock Shares Heldin Trust
TreasuryStockSharesHeldinTrust
1000000 shares
CY2016Q4 cvs Treasury Stock Value Shares Held In Trust
TreasuryStockValueSharesHeldInTrust
31000000 USD
CY2019Q3 dei Amendment Flag
AmendmentFlag
false
CY2019Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2019Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019Q3 dei Entity Central Index Key
EntityCentralIndexKey
0000064803
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3200000000 shares
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3200000000 shares
CY2017Q4 us-gaap Common Stock Shares Held In Employee Trust Shares
CommonStockSharesHeldInEmployeeTrustShares
1000000 shares
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1712000000 shares
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1720000000 shares
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1014000000 shares
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1295000000 shares
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
17000000 USD
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
17000000 USD
CY2017 us-gaap Depreciation
Depreciation
1700000000 USD
CY2016 us-gaap Depreciation
Depreciation
1700000000 USD
CY2018Q1 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.50
CY2018Q2 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.50
CY2018Q3 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.50
CY2016 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
CY2017Q1 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.50
CY2017Q2 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.50
CY2017Q3 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.50
CY2017Q4 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.50
CY2017 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
CY2016 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 USD
CY2017 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 USD
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000 shares
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000 shares
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
698000000 shares
CY2018Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
425000000 shares
CY2019Q3 dei Document Type
DocumentType
8-K
CY2019Q3 dei Document Period End Date
DocumentPeriodEndDate
2019-08-08
CY2019Q3 dei Entity Registrant Name
EntityRegistrantName
CVS HEALTH CORP
CY2019Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2019Q3 dei Entity File Number
EntityFileNumber
001-01011
CY2019Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
05-0494040
CY2019Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
One CVS Drive
CY2019Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
Woonsocket
CY2019Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
RI
CY2019Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02895
CY2019Q3 dei City Area Code
CityAreaCode
401
CY2019Q3 dei Local Phone Number
LocalPhoneNumber
765-1500
CY2019Q3 dei Written Communications
WrittenCommunications
false
CY2019Q3 dei Soliciting Material
SolicitingMaterial
false
CY2019Q3 dei Pre Commencement Tender Offer
PreCommencementTenderOffer
false
CY2019Q3 dei Pre Commencement Issuer Tender Offer
PreCommencementIssuerTenderOffer
false
CY2019Q3 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
CY2019Q3 dei Trading Symbol
TradingSymbol
CVS
CY2018 us-gaap Net Investment Income
NetInvestmentIncome
660000000 USD
CY2017 us-gaap Net Investment Income
NetInvestmentIncome
21000000 USD
CY2016 us-gaap Net Investment Income
NetInvestmentIncome
20000000 USD
CY2018 us-gaap Revenues
Revenues
194579000000 USD
CY2017 us-gaap Revenues
Revenues
184786000000 USD
CY2016 us-gaap Revenues
Revenues
177546000000 USD
CY2019Q3 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2019Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2018 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
156447000000 USD
CY2017 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
153448000000 USD
CY2016 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
146533000000 USD
CY2018 us-gaap Policyholder Benefits And Claims Incurred Net
PolicyholderBenefitsAndClaimsIncurredNet
6594000000 USD
CY2017 us-gaap Policyholder Benefits And Claims Incurred Net
PolicyholderBenefitsAndClaimsIncurredNet
2810000000 USD
CY2016 us-gaap Policyholder Benefits And Claims Incurred Net
PolicyholderBenefitsAndClaimsIncurredNet
2179000000 USD
CY2018 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
6149000000 USD
CY2017 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
181000000 USD
CY2016 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2018 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
21368000000 USD
CY2017 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
18809000000 USD
CY2016 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
18448000000 USD
CY2018 us-gaap Costs And Expenses
CostsAndExpenses
190558000000 USD
CY2017 us-gaap Costs And Expenses
CostsAndExpenses
175248000000 USD
CY2016 us-gaap Costs And Expenses
CostsAndExpenses
167160000000 USD
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
4021000000 USD
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
9538000000 USD
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
10386000000 USD
CY2018 us-gaap Interest Expense
InterestExpense
2619000000 USD
CY2017 us-gaap Interest Expense
InterestExpense
1062000000 USD
CY2016 us-gaap Interest Expense
InterestExpense
1078000000 USD
CY2018 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2017 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2016 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-643000000 USD
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4000000 USD
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-208000000 USD
CY2016 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-28000000 USD
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1406000000 USD
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8268000000 USD
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8637000000 USD
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2002000000 USD
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1637000000 USD
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3317000000 USD
CY2018 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-596000000 USD
CY2017 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
6631000000 USD
CY2016 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
5320000000 USD
CY2018 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0 USD
CY2017 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-8000000 USD
CY2016 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-1000000 USD
CY2018 us-gaap Profit Loss
ProfitLoss
-596000000 USD
CY2017 us-gaap Profit Loss
ProfitLoss
6623000000 USD
CY2016 us-gaap Profit Loss
ProfitLoss
5319000000 USD
CY2018 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2000000 USD
CY2017 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000 USD
CY2016 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2000000 USD
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-594000000 USD
CY2017 us-gaap Net Income Loss
NetIncomeLoss
6622000000 USD
CY2016 us-gaap Net Income Loss
NetIncomeLoss
5317000000 USD
CY2018 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.57
CY2017 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
6.48
CY2016 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
4.93
CY2018 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2017 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.01
CY2016 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2018 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.57
CY2017 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.47
CY2016 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.93
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1044000000 shares
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1020000000 shares
CY2016 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1073000000 shares
CY2018 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.57
CY2017 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
6.45
CY2016 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
4.91
CY2018 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2017 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.01
CY2016 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2018 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.57
CY2017 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.44
CY2016 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.90
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1044000000 shares
CY2017 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1024000000 shares
CY2016 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1079000000 shares
CY2018 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.00
CY2017 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.00
CY2016 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.70
CY2017Q4 us-gaap Long Term Investments
LongTermInvestments
112000000 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11349000000 USD
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10292000000 USD
CY2018Q4 us-gaap Goodwill
Goodwill
78678000000 USD
CY2017Q4 us-gaap Goodwill
Goodwill
38451000000 USD
CY2018 us-gaap Profit Loss
ProfitLoss
-596000000 USD
CY2017 us-gaap Profit Loss
ProfitLoss
6623000000 USD
CY2016 us-gaap Profit Loss
ProfitLoss
5319000000 USD
CY2018 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
97000000 USD
CY2017 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
0 USD
CY2016 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
0 USD
CY2018 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-29000000 USD
CY2017 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2000000 USD
CY2016 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
38000000 USD
CY2018 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
330000000 USD
CY2017 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-10000000 USD
CY2016 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
2000000 USD
CY2018 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
124000000 USD
CY2017 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-152000000 USD
CY2016 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-13000000 USD
CY2018 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
274000000 USD
CY2017 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
140000000 USD
CY2016 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
53000000 USD
CY2018 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-322000000 USD
CY2017 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
6763000000 USD
CY2016 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
5372000000 USD
CY2018 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-2000000 USD
CY2017 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
1000000 USD
CY2016 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
2000000 USD
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-320000000 USD
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6762000000 USD
CY2016 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5370000000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4059000000 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1696000000 USD
CY2018Q4 us-gaap Short Term Investments
ShortTermInvestments
2522000000 USD
CY2017Q4 us-gaap Short Term Investments
ShortTermInvestments
111000000 USD
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
17631000000 USD
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
13181000000 USD
CY2018Q4 us-gaap Inventory Net
InventoryNet
16450000000 USD
CY2017Q4 us-gaap Inventory Net
InventoryNet
15296000000 USD
CY2018Q4 us-gaap Other Assets Current
OtherAssetsCurrent
4581000000 USD
CY2017Q4 us-gaap Other Assets Current
OtherAssetsCurrent
945000000 USD
CY2018Q4 us-gaap Assets Current
AssetsCurrent
45243000000 USD
CY2017Q4 us-gaap Assets Current
AssetsCurrent
31229000000 USD
CY2018Q4 us-gaap Long Term Investments
LongTermInvestments
15732000000 USD
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
36524000000 USD
CY2017Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
13630000000 USD
CY2018Q4 us-gaap Separate Account Assets
SeparateAccountAssets
3884000000 USD
CY2017Q4 us-gaap Separate Account Assets
SeparateAccountAssets
0 USD
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5046000000 USD
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1417000000 USD
CY2018Q4 us-gaap Assets
Assets
196456000000 USD
CY2017Q4 us-gaap Assets
Assets
95131000000 USD
CY2018Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
8925000000 USD
CY2017Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
8863000000 USD
CY2018Q4 cvs Pharmacy Claimsand Discounts Payable Current
PharmacyClaimsandDiscountsPayableCurrent
11365000000 USD
CY2017Q4 cvs Pharmacy Claimsand Discounts Payable Current
PharmacyClaimsandDiscountsPayableCurrent
10355000000 USD
CY2018Q4 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Net
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
6147000000 USD
CY2017Q4 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Net
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
5000000 USD
CY2018Q4 us-gaap Other Policyholder Funds
OtherPolicyholderFunds
2939000000 USD
CY2017Q4 us-gaap Other Policyholder Funds
OtherPolicyholderFunds
0 USD
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10711000000 USD
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6581000000 USD
CY2018Q4 cvs Other Insurance Liabilities Current
OtherInsuranceLiabilitiesCurrent
1937000000 USD
CY2017Q4 cvs Other Insurance Liabilities Current
OtherInsuranceLiabilitiesCurrent
23000000 USD
CY2018Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
720000000 USD
CY2017Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
1276000000 USD
CY2018Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1265000000 USD
CY2017Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
3545000000 USD
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
44009000000 USD
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
30648000000 USD
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
71444000000 USD
CY2017Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
22181000000 USD
CY2018Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
7677000000 USD
CY2017Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2996000000 USD
CY2018Q4 us-gaap Separate Accounts Liability
SeparateAccountsLiability
3884000000 USD
CY2017Q4 us-gaap Separate Accounts Liability
SeparateAccountsLiability
0 USD
CY2018Q4 cvs Other Insurance Liabilities Noncurrent
OtherInsuranceLiabilitiesNoncurrent
8119000000 USD
CY2017Q4 cvs Other Insurance Liabilities Noncurrent
OtherInsuranceLiabilitiesNoncurrent
334000000 USD
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2780000000 USD
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1277000000 USD
CY2018Q4 us-gaap Liabilities
Liabilities
137913000000 USD
CY2017Q4 us-gaap Liabilities
Liabilities
57436000000 USD
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2018Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
45440000000 USD
CY2017Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
32096000000 USD
CY2018Q4 us-gaap Treasury Stock Value
TreasuryStockValue
28228000000 USD
CY2017Q4 us-gaap Treasury Stock Value
TreasuryStockValue
37796000000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
40911000000 USD
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
43556000000 USD
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
102000000 USD
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-165000000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
58225000000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
37691000000 USD
CY2018Q4 us-gaap Minority Interest
MinorityInterest
318000000 USD
CY2017Q4 us-gaap Minority Interest
MinorityInterest
4000000 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
58543000000 USD
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
37695000000 USD
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
196456000000 USD
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
95131000000 USD
CY2018 us-gaap Proceeds From Customers
ProceedsFromCustomers
186519000000 USD
CY2017 us-gaap Proceeds From Customers
ProceedsFromCustomers
176594000000 USD
CY2016 us-gaap Proceeds From Customers
ProceedsFromCustomers
172310000000 USD
CY2018 cvs Paymentsfor Inventoryand Prescriptions Dispensedby Retail Network Pharmacies
PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies
148981000000 USD
CY2017 cvs Paymentsfor Inventoryand Prescriptions Dispensedby Retail Network Pharmacies
PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies
146469000000 USD
CY2016 cvs Paymentsfor Inventoryand Prescriptions Dispensedby Retail Network Pharmacies
PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies
140312000000 USD
CY2018 cvs Paymentsfor Insurance Benefits
PaymentsforInsuranceBenefits
6897000000 USD
CY2017 cvs Paymentsfor Insurance Benefits
PaymentsforInsuranceBenefits
2810000000 USD
CY2016 cvs Paymentsfor Insurance Benefits
PaymentsforInsuranceBenefits
2199000000 USD
CY2018 us-gaap Payments To Suppliers And Employees
PaymentsToSuppliersAndEmployees
17234000000 USD
CY2017 us-gaap Payments To Suppliers And Employees
PaymentsToSuppliersAndEmployees
15348000000 USD
CY2016 us-gaap Payments To Suppliers And Employees
PaymentsToSuppliersAndEmployees
15478000000 USD
CY2018 us-gaap Proceeds From Interest And Dividends Received
ProceedsFromInterestAndDividendsReceived
644000000 USD
CY2017 us-gaap Proceeds From Interest And Dividends Received
ProceedsFromInterestAndDividendsReceived
21000000 USD
CY2016 us-gaap Proceeds From Interest And Dividends Received
ProceedsFromInterestAndDividendsReceived
20000000 USD
CY2018 us-gaap Interest Paid Net
InterestPaidNet
2803000000 USD
CY2017 us-gaap Interest Paid Net
InterestPaidNet
1072000000 USD
CY2016 us-gaap Interest Paid Net
InterestPaidNet
1140000000 USD
CY2018 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2383000000 USD
CY2017 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2909000000 USD
CY2016 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3060000000 USD
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8865000000 USD
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8007000000 USD
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
10141000000 USD
CY2018 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
817000000 USD
CY2017 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
61000000 USD
CY2016 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
91000000 USD
CY2018 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
692000000 USD
CY2017 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
137000000 USD
CY2016 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
80000000 USD
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2037000000 USD
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1918000000 USD
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2224000000 USD
CY2018 us-gaap Sale Leaseback Transaction Net Proceeds Investing Activities
SaleLeasebackTransactionNetProceedsInvestingActivities
0 USD
CY2017 us-gaap Sale Leaseback Transaction Net Proceeds Investing Activities
SaleLeasebackTransactionNetProceedsInvestingActivities
265000000 USD
CY2016 us-gaap Sale Leaseback Transaction Net Proceeds Investing Activities
SaleLeasebackTransactionNetProceedsInvestingActivities
230000000 USD
CY2018 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
42226000000 USD
CY2017 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1181000000 USD
CY2016 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
524000000 USD
CY2018 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
832000000 USD
CY2017 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
0 USD
CY2016 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
0 USD
CY2018 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-21000000 USD
CY2017 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-33000000 USD
CY2016 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-37000000 USD
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-43285000000 USD
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2877000000 USD
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2470000000 USD
CY2018 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-556000000 USD
CY2017 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-598000000 USD
CY2016 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
1874000000 USD
CY2018 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
44343000000 USD
CY2017 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
CY2016 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
3455000000 USD
CY2018 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
5522000000 USD
CY2017 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
CY2016 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
5943000000 USD
CY2018 us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
0 USD
CY2017 us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
0 USD
CY2016 us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
-39000000 USD
CY2018 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0 USD
CY2017 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0 USD
CY2016 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
26000000 USD
CY2018 us-gaap Payments For Proceeds From Derivative Instrument Financing Activities
PaymentsForProceedsFromDerivativeInstrumentFinancingActivities
-446000000 USD
CY2017 us-gaap Payments For Proceeds From Derivative Instrument Financing Activities
PaymentsForProceedsFromDerivativeInstrumentFinancingActivities
0 USD
CY2016 us-gaap Payments For Proceeds From Derivative Instrument Financing Activities
PaymentsForProceedsFromDerivativeInstrumentFinancingActivities
0 USD
CY2018 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
CY2017 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4361000000 USD
CY2016 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4461000000 USD
CY2018 us-gaap Payments Of Dividends
PaymentsOfDividends
2038000000 USD
CY2017 us-gaap Payments Of Dividends
PaymentsOfDividends
2049000000 USD
CY2016 us-gaap Payments Of Dividends
PaymentsOfDividends
1840000000 USD
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
242000000 USD
CY2017 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
329000000 USD
CY2016 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
296000000 USD
CY2018 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
97000000 USD
CY2017 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
71000000 USD
CY2016 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
72000000 USD
CY2018 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
1000000 USD
CY2017 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-1000000 USD
CY2016 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-5000000 USD
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
36819000000 USD
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6751000000 USD
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6761000000 USD
CY2018 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-4000000 USD
CY2017 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1000000 USD
CY2016 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2000000 USD
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2395000000 USD
CY2017 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1620000000 USD
CY2016 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
912000000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1900000000 USD
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3520000000 USD
CY2015Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2608000000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4295000000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1900000000 USD
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3520000000 USD
CY2018 us-gaap Profit Loss
ProfitLoss
-596000000 USD
CY2017 us-gaap Profit Loss
ProfitLoss
6623000000 USD
CY2016 us-gaap Profit Loss
ProfitLoss
5319000000 USD
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2718000000 USD
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2479000000 USD
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2475000000 USD
CY2018 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
6149000000 USD
CY2017 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
181000000 USD
CY2016 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2018 us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Settlements1
DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
0 USD
CY2017 us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Settlements1
DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
-187000000 USD
CY2016 us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Settlements1
DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
0 USD
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
280000000 USD
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
234000000 USD
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
222000000 USD
CY2018 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2017 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2016 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-643000000 USD
CY2018 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
87000000 USD
CY2017 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-1334000000 USD
CY2016 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
18000000 USD
CY2018 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-339000000 USD
CY2017 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-53000000 USD
CY2016 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-135000000 USD
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1139000000 USD
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
941000000 USD
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
243000000 USD
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1153000000 USD
CY2017 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
514000000 USD
CY2016 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
742000000 USD
CY2018 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
3000000 USD
CY2017 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
338000000 USD
CY2016 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
8000000 USD
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2329000000 USD
CY2017 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1710000000 USD
CY2016 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2189000000 USD
CY2018 us-gaap Increase Decrease In Insurance Liabilities
IncreaseDecreaseInInsuranceLiabilities
-311000000 USD
CY2017 us-gaap Increase Decrease In Insurance Liabilities
IncreaseDecreaseInInsuranceLiabilities
0 USD
CY2016 us-gaap Increase Decrease In Insurance Liabilities
IncreaseDecreaseInInsuranceLiabilities
-19000000 USD
CY2018 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
165000000 USD
CY2017 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-333000000 USD
CY2016 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
152000000 USD
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8865000000 USD
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8007000000 USD
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
10141000000 USD
CY2015Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
37203000000 USD
CY2016 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
5318000000 USD
CY2016 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
53000000 USD
CY2016 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
525000000 USD
CY2016 cvs Treasury Stock Value Acquired Cost Method Net Of Espp Issuance
TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
4421000000 USD
CY2016 us-gaap Dividends Common Stock
DividendsCommonStock
1840000000 USD
CY2016 cvs Noncontrollinginterest Other Period Increase Decrease
NoncontrollinginterestOtherPeriodIncreaseDecrease
-4000000 USD
CY2016Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
36834000000 USD
CY2017 us-gaap Profit Loss
ProfitLoss
6623000000 USD
CY2017 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
140000000 USD
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
461000000 USD
CY2017 cvs Treasury Stock Value Acquired Cost Method Net Of Espp Issuance
TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
4313000000 USD
CY2017 us-gaap Dividends Common Stock
DividendsCommonStock
2049000000 USD
CY2017 cvs Noncontrollinginterest Other Period Increase Decrease
NoncontrollinginterestOtherPeriodIncreaseDecrease
-1000000 USD
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
37695000000 USD
CY2018Q4 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
-13000000 USD
CY2018 us-gaap Profit Loss
ProfitLoss
-596000000 USD
CY2018 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
274000000 USD
CY2018 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
22484000000 USD
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
421000000 USD
CY2018 cvs Treasury Stock Value Acquired Cost Method Net Of Espp Issuance
TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
-7000000 USD
CY2018 us-gaap Dividends Common Stock
DividendsCommonStock
2045000000 USD
CY2018 cvs Noncontrollinginterest Other Period Increase Decrease
NoncontrollinginterestOtherPeriodIncreaseDecrease
-13000000 USD
CY2018 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
329000000 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
58543000000 USD
CY2018Q4 cvs Treasury Stock Shares Heldin Trust
TreasuryStockSharesHeldinTrust
1000000 shares
CY2018Q4 cvs Treasury Stock Value Shares Held In Trust
TreasuryStockValueSharesHeldInTrust
29000000 USD
CY2017Q4 cvs Treasury Stock Value Shares Held In Trust
TreasuryStockValueSharesHeldInTrust
31000000 USD
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
17000000 USD
CY2016 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
1000000 USD
CY2018Q4 us-gaap Number Of Stores
NumberOfStores
9900 store
CY2018Q4 cvs Numberof Walk In Medical Clinics
NumberofWalkInMedicalClinics
1100 clinic
CY2018Q4 cvs Number Of Plan Members
NumberOfPlanMembers
92000000 memeber
CY2018Q4 cvs Numberof Patients Servedper Year
NumberofPatientsServedperYear
1000000 patient
CY2018Q4 cvs Number Of People Served
NumberOfPeopleServed
38000000 person
CY2018 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4 Segment
CY2018Q4 cvs Number Of People Served
NumberOfPeopleServed
38000000 person
CY2018 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Reclassifications</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Certain prior year amounts have been reclassified to conform with the current year presentation.</span></div>
CY2018 us-gaap Use Of Estimates
UseOfEstimates
<div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates. </span></div>
CY2018Q4 us-gaap Restricted Cash
RestrictedCash
230000000 USD
CY2017Q4 us-gaap Restricted Cash
RestrictedCash
190000000 USD
CY2018Q4 us-gaap Escrow Deposit
EscrowDeposit
6000000 USD
CY2017Q4 us-gaap Escrow Deposit
EscrowDeposit
14000000 USD
CY2018Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
6896000000 USD
CY2017Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
7895000000 USD
CY2018Q4 cvs Vendor And Manufacturer Receivables Net Current
VendorAndManufacturerReceivablesNetCurrent
7655000000 USD
CY2017Q4 cvs Vendor And Manufacturer Receivables Net Current
VendorAndManufacturerReceivablesNetCurrent
5109000000 USD
CY2018Q4 us-gaap Premiums Receivable At Carrying Value
PremiumsReceivableAtCarryingValue
2259000000 USD
CY2017Q4 us-gaap Premiums Receivable At Carrying Value
PremiumsReceivableAtCarryingValue
31000000 USD
CY2018Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
821000000 USD
CY2017Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
146000000 USD
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
17631000000 USD
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
13181000000 USD
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
307000000 USD
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
286000000 USD
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
161000000 USD
CY2018 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
256000000 USD
CY2017 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
177000000 USD
CY2016 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
221000000 USD
CY2018 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
70000000 USD
CY2017 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
156000000 USD
CY2016 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
96000000 USD
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
493000000 USD
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
307000000 USD
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
286000000 USD
CY2018Q4 us-gaap Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation
CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation
163000000 USD
CY2018Q4 us-gaap Deferred Policy Acquisition Costs
DeferredPolicyAcquisitionCosts
22000000 USD
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
26869000000 USD
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
24290000000 USD
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
15520000000 USD
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
13998000000 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11349000000 USD
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10292000000 USD
CY2018Q4 us-gaap Capital Leased Assets Gross
CapitalLeasedAssetsGross
582000000 USD
CY2017Q4 us-gaap Capital Leased Assets Gross
CapitalLeasedAssetsGross
588000000 USD
CY2017Q4 us-gaap Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation
CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation
140000000 USD
CY2018Q4 us-gaap Capital Leases Balance Sheet Assets By Major Class Net
CapitalLeasesBalanceSheetAssetsByMajorClassNet
419000000 USD
CY2017Q4 us-gaap Capital Leases Balance Sheet Assets By Major Class Net
CapitalLeasesBalanceSheetAssetsByMajorClassNet
448000000 USD
CY2018 us-gaap Depreciation
Depreciation
1700000000 USD
CY2018 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
CY2018 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 USD
CY2018Q4 cvs Assumed Interest Rates On Long Duration Group Life And Long Term Care Contracts
AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts
0.051
CY2018Q4 cvs Premium Deficiency Reserve Liability
PremiumDeficiencyReserveLiability
16000000 USD
CY2018 us-gaap Allocations To Policyholders Policies
AllocationsToPolicyholdersPolicies
<div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Policyholders’ Funds</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Policyholders’ funds consist primarily of reserves for pension and annuity investment contracts and customer funds associated with certain health contracts. Reserves for such contracts are equal to cumulative deposits less withdrawals and charges plus credited interest thereon, net of experience-rated adjustments. From the Aetna Acquisition Date through </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;">, interest rates for pension and annuity investment contracts ranged from </span><span style="font-family:inherit;font-size:10pt;"><span>3.5%</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>13.4%</span></span><span style="font-family:inherit;font-size:10pt;">. Reserves for contracts subject to experience rating reflect the Company’s rights as well as the rights of policyholders and plan participants. The Company also holds funds for health savings accounts (“HSAs”) on behalf of members associated with high deductible health plans. These amounts are held to pay for qualified health care expenses incurred by these members. The HSA balances were approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$2.1 billion</span></span><span style="font-family:inherit;font-size:10pt;"> at </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> and are reflected in other current assets with a corresponding liability in policyholder funds. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Policyholders’ Funds liabilities that are expected to be paid within twelve months from the balance sheet date are classified as current on the consolidated balance sheets. Policyholders’ Funds liabilities that are expected to be paid greater than twelve months from the balance sheet date are included in other long-term liabilities on the consolidated balance sheets. </span></div>
CY2018Q4 us-gaap Policyholder Funds
PolicyholderFunds
2100000000 USD
CY2018Q4 us-gaap Self Insurance Reserve
SelfInsuranceReserve
865000000 USD
CY2017Q4 us-gaap Self Insurance Reserve
SelfInsuranceReserve
696000000 USD
CY2017 cvs Number Of Stores Closed
NumberOfStoresClosed
71 store
CY2017 us-gaap Restructuring Charges
RestructuringCharges
215000000 USD
CY2018Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
269000000 USD
CY2017Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
306000000 USD
CY2015Q4 us-gaap Minority Interest Ownership Percentage By Parent
MinorityInterestOwnershipPercentageByParent
0.73
CY2016 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
39000000 USD
CY2015Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
39000000 USD
CY2016 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
1000000 USD
CY2016 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
2000000 USD
CY2016 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
39000000 USD
CY2016 cvs Noncontrolling Interest Increase From Reclassifications
NoncontrollingInterestIncreaseFromReclassifications
1000000 USD
CY2016Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
0 USD
CY2018 us-gaap Net Investment Income
NetInvestmentIncome
660000000 USD
CY2018 us-gaap Revenues
Revenues
194579000000 USD
CY2018Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
6896000000 USD
CY2017Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
7895000000 USD
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
67000000 USD
CY2017Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
53000000 USD
CY2017Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
53000000 USD
CY2018 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
17000000 USD
CY2018 cvs Contract With Customer Liability Loyalty Program Earnings And Gift Card Issuance
ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance
332000000 USD
CY2018 cvs Contract With Customer Liability Redemption And Breakage
ContractWithCustomerLiabilityRedemptionAndBreakage
335000000 USD
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
67000000 USD
CY2018 cvs Pharmacy Rebate Period
PharmacyRebatePeriod
P30D
CY2018 cvs Health Insurer Fee
HealthInsurerFee
157000000 USD
CY2016 cvs Health Insurer Fee
HealthInsurerFee
56000000 USD
CY2017 cvs Health Insurer Fee
HealthInsurerFee
0 USD
CY2018 cvs Expected Health Insurer Fees
ExpectedHealthInsurerFees
0 USD
CY2018 us-gaap Advertising Expense
AdvertisingExpense
364000000 USD
CY2017 us-gaap Advertising Expense
AdvertisingExpense
230000000 USD
CY2016 us-gaap Advertising Expense
AdvertisingExpense
216000000 USD
CY2016 cvs Pre Tcja Effective Tax Rate
PreTCJAEffectiveTaxRate
0.35
CY2017 cvs Tcja Effective Tax Rate
TCJAEffectiveTaxRate
0.21
CY2017Q4 cvs Remeasured Dt Aunder Tcja
RemeasuredDTAunderTCJA
1500000000 USD
CY2018Q4 cvs Remeasured Dt Aunder Tcja
RemeasuredDTAunderTCJA
100000000 USD
CY2018Q4 us-gaap Common Stock Shares Held In Employee Trust Shares
CommonStockSharesHeldInEmployeeTrustShares
1000000000000 shares
CY2014 us-gaap Variable Interest Entity Ownership Percentage
VariableInterestEntityOwnershipPercentage
0.50
CY2014Q3 cvs Initialcontractualterm
Initialcontractualterm
P10Y
CY2016Q4 cvs Number Of Quarterly Payments From Variable Interest Entity
NumberOfQuarterlyPaymentsFromVariableInterestEntity
39 payment
CY2018 cvs Proceeds From Variable Interest Entity
ProceedsFromVariableInterestEntity
183000000 USD
CY2016 cvs Proceeds From Variable Interest Entity
ProceedsFromVariableInterestEntity
163000000 USD
CY2018 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
45000000 USD
CY2017 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
35000000 USD
CY2016 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
39000000 USD
CY2018 us-gaap Related Party Transaction Other Revenues From Transactions With Related Party
RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
135000000 USD
CY2017 us-gaap Related Party Transaction Other Revenues From Transactions With Related Party
RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
139000000 USD
CY2016 us-gaap Related Party Transaction Other Revenues From Transactions With Related Party
RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
140000000 USD
CY2017 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-13000000 USD
CY2016 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-2000000 USD
CY2017 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-5000000 USD
CY2016 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-1000000 USD
CY2017 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-8000000 USD
CY2016 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-1000000 USD
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6581000000 USD
CY2017Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2996000000 USD
CY2017Q4 us-gaap Liabilities
Liabilities
57436000000 USD
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
43556000000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
37691000000 USD
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
37695000000 USD
CY2018 us-gaap Revenues
Revenues
194579000000 USD
CY2018 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
156447000000 USD
CY2018 us-gaap Costs And Expenses
CostsAndExpenses
190558000000 USD
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
4021000000 USD
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1406000000 USD
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2002000000 USD
CY2018 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-596000000 USD
CY2018 us-gaap Profit Loss
ProfitLoss
-596000000 USD
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-594000000 USD
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10711000000 USD
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
44009000000 USD
CY2018Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
7677000000 USD
CY2018Q4 us-gaap Liabilities
Liabilities
137913000000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
40911000000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
58225000000 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
58543000000 USD
CY2018 us-gaap Profit Loss
ProfitLoss
-596000000 USD
CY2018 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
165000000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4059000000 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1696000000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3371000000 USD
CY2018Q4 us-gaap Escrow Deposit
EscrowDeposit
6000000 USD
CY2017Q4 us-gaap Escrow Deposit
EscrowDeposit
14000000 USD
CY2016Q4 us-gaap Escrow Deposit
EscrowDeposit
0 USD
CY2018Q4 us-gaap Restricted Cash
RestrictedCash
230000000 USD
CY2017Q4 us-gaap Restricted Cash
RestrictedCash
190000000 USD
CY2016Q4 us-gaap Restricted Cash
RestrictedCash
149000000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4295000000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1900000000 USD
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3520000000 USD
CY2017 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1181000000 USD
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2877000000 USD
CY2017 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1620000000 USD
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3520000000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1900000000 USD
CY2016 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
524000000 USD
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2470000000 USD
CY2016 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
912000000 USD
CY2015Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2608000000 USD
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3520000000 USD
CY2018Q4 us-gaap Number Of Stores
NumberOfStores
9900 store
CY2018Q4 cvs Numberof Walk In Medical Clinics
NumberofWalkInMedicalClinics
1100 clinic
CY2018 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
243232000000 USD
CY2017 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
236000000000 USD
CY2018 us-gaap Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax
BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax
1152000000 USD
CY2017 us-gaap Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax
BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax
6813000000 USD
CY2018 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
0.89
CY2017 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
5.25
CY2018 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
0.88
CY2017 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
5.21
CY2017Q4 us-gaap Long Term Investments
LongTermInvestments
112000000 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
2359000000 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
12896000000 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
15255000000 USD
CY2018Q4 cvs Mortgage Loanson Real Estate Commercialand Consumer Net Current
MortgageLoansonRealEstateCommercialandConsumerNetCurrent
145000000 USD
CY2018Q4 cvs Mortgage Loanson Real Estate Commercialand Consumer Net Noncurrent
MortgageLoansonRealEstateCommercialandConsumerNetNoncurrent
1216000000 USD
CY2018Q4 us-gaap Mortgage Loans On Real Estate Commercial And Consumer Net
MortgageLoansOnRealEstateCommercialAndConsumerNet
1361000000 USD
CY2018Q4 us-gaap Other Short Term Investments
OtherShortTermInvestments
18000000 USD
CY2018Q4 us-gaap Other Long Term Investments
OtherLongTermInvestments
1620000000 USD
CY2018Q4 us-gaap Other Investments
OtherInvestments
1638000000 USD
CY2018Q4 us-gaap Short Term Investments
ShortTermInvestments
2522000000 USD
CY2018Q4 us-gaap Long Term Investments
LongTermInvestments
15732000000 USD
CY2018Q4 us-gaap Investments
Investments
18254000000 USD
CY2018Q4 us-gaap Restricted Investments At Fair Value
RestrictedInvestmentsAtFairValue
531000000 USD
CY2018Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
15119000000 USD
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
172000000 USD
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
36000000 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
15255000000 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
901000000 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
902000000 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
5489000000 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
5521000000 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
2973000000 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
2999000000 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
3498000000 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
3566000000 USD
CY2018Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
15119000000 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
15255000000 USD
CY2018Q4 us-gaap Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1
2279 security
CY2018Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
2409000000 USD
CY2018Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
36000000 USD
CY2018Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
2409000000 USD
CY2018Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
36000000 USD
CY2018 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
660000000 USD
CY2018 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
3000000 USD
CY2018 cvs Investment Income Excluding Capital Gains
InvestmentIncomeExcludingCapitalGains
657000000 USD
CY2018 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
3000000 USD
CY2018 us-gaap Investment Income Net
InvestmentIncomeNet
660000000 USD
CY2018Q4 us-gaap Derivative Collateral Obligation To Return Securities
DerivativeCollateralObligationToReturnSecurities
13000000 USD
CY2016Q4 us-gaap Goodwill
Goodwill
38249000000 USD
CY2017 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
385000000 USD
CY2017 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-2000000 USD
CY2017 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
181000000 USD
CY2017Q4 us-gaap Goodwill
Goodwill
38451000000 USD
CY2018 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
46788000000 USD
CY2018 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-14000000 USD
CY2018 us-gaap Goodwill Written Off Related To Sale Of Business Unit
GoodwillWrittenOffRelatedToSaleOfBusinessUnit
398000000 USD
CY2018 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
6149000000 USD
CY2018Q4 us-gaap Goodwill
Goodwill
78678000000 USD
CY2018Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
43738000000 USD
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
7214000000 USD
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
36524000000 USD
CY2018 us-gaap Finite Lived Intangible Asset Weighted Average Period Before Next Renewal Or Extension
FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension
P15Y3M18D
CY2017Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
19929000000 USD
CY2017Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6299000000 USD
CY2017Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
13630000000 USD
CY2017 us-gaap Finite Lived Intangible Asset Weighted Average Period Before Next Renewal Or Extension
FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension
P15Y4M24D
CY2018 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1000000000.0 USD
CY2017 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
817000000 USD
CY2016 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
795000000 USD
CY2018Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2563000000 USD
CY2018Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2350000000 USD
CY2018Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2253000000 USD
CY2018Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1879000000 USD
CY2018Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
1844000000 USD
CY2018 us-gaap Operating Leases Rent Expense Minimum Rentals
OperatingLeasesRentExpenseMinimumRentals
2528000000 USD
CY2017 us-gaap Operating Leases Rent Expense Minimum Rentals
OperatingLeasesRentExpenseMinimumRentals
2455000000 USD
CY2016 us-gaap Operating Leases Rent Expense Minimum Rentals
OperatingLeasesRentExpenseMinimumRentals
2418000000 USD
CY2018 us-gaap Operating Leases Rent Expense Contingent Rentals
OperatingLeasesRentExpenseContingentRentals
28000000 USD
CY2017 us-gaap Operating Leases Rent Expense Contingent Rentals
OperatingLeasesRentExpenseContingentRentals
29000000 USD
CY2016 us-gaap Operating Leases Rent Expense Contingent Rentals
OperatingLeasesRentExpenseContingentRentals
35000000 USD
CY2018 cvs Operating Leases Rent Expense Gross
OperatingLeasesRentExpenseGross
2556000000 USD
CY2017 cvs Operating Leases Rent Expense Gross
OperatingLeasesRentExpenseGross
2484000000 USD
CY2016 cvs Operating Leases Rent Expense Gross
OperatingLeasesRentExpenseGross
2453000000 USD
CY2018 us-gaap Operating Leases Rent Expense Sublease Rentals1
OperatingLeasesRentExpenseSubleaseRentals1
21000000 USD
CY2017 us-gaap Operating Leases Rent Expense Sublease Rentals1
OperatingLeasesRentExpenseSubleaseRentals1
24000000 USD
CY2016 us-gaap Operating Leases Rent Expense Sublease Rentals1
OperatingLeasesRentExpenseSubleaseRentals1
24000000 USD
CY2018 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
2535000000 USD
CY2017 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
2460000000 USD
CY2016 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
2429000000 USD
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
74000000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
2690000000 USD
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
73000000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
2544000000 USD
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
73000000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
2399000000 USD
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
73000000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
2233000000 USD
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
73000000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
2110000000 USD
CY2017Q4 us-gaap Long Term Debt
LongTermDebt
27002000000 USD
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due Thereafter
CapitalLeasesFutureMinimumPaymentsDueThereafter
875000000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
16004000000 USD
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
1241000000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
27980000000 USD
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
599000000 USD
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments
CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments
642000000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals
OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals
164000000 USD
CY2018Q4 cvs Operating And Capital Leases Amount Due In Excess Of Remaining Estimated Economic Life
OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife
2100000000 USD
CY2018 us-gaap Sale Leaseback Transaction Net Proceeds Investing Activities
SaleLeasebackTransactionNetProceedsInvestingActivities
0 USD
CY2017 us-gaap Sale Leaseback Transaction Net Proceeds Investing Activities
SaleLeasebackTransactionNetProceedsInvestingActivities
265000000 USD
CY2016 us-gaap Sale Leaseback Transaction Net Proceeds Investing Activities
SaleLeasebackTransactionNetProceedsInvestingActivities
230000000 USD
CY2018 us-gaap Schedule Of Liability For Unpaid Claims And Claims Adjustment Expense
ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense
<div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table shows the components of the change in health care costs payable during 2018:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:89%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">In millions</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Health care costs payable, beginning of the period </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: Reinsurance recoverables</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Health care costs payable, beginning of the period, net</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Acquisitions, net</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,357</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Reclassification from pharmacy claims and discounts payable </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>776</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Add: Components of incurred health care costs</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">  Current year</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,594</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">  Prior years</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(42</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total incurred health care costs </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,552</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: Claims paid</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">  Current year</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,303</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">  Prior years</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>260</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total claims paid</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,563</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Add: Premium deficiency reserve</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Health care costs payable, end of period, net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,143</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Add: Reinsurance recoverables</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Health care costs payable, end of period</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,147</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">_____________________________________________</sup> </span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:inherit;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">As of the Aetna Acquisition Date, the Company reclassified </span><span style="font-family:inherit;font-size:8pt;"><span>$776 million</span></span><span style="font-family:inherit;font-size:8pt;"> of the Pharmacy Services segment’s unpaid retail pharmacy claims to third parties from pharmacy claims and discounts payable to health care costs payable as the third party liability was incurred to support the Health Care Benefits segment’s fully insured members.</span></div></td></tr></table><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:inherit;font-size:8pt;">(2)</span></div><div style="line-height:120%;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Total incurred health care costs for the year ended </span><span style="font-family:inherit;font-size:8pt;">December 31, 2018</span><span style="font-family:inherit;font-size:8pt;"> in the table above exclude (i) </span><span style="font-family:inherit;font-size:8pt;"><span>$16 million</span></span><span style="font-family:inherit;font-size:8pt;"> related to a premium deficiency reserve for the 2019 coverage year related to Medicaid products, (ii) </span><span style="font-family:inherit;font-size:8pt;"><span>$4 million</span></span><span style="font-family:inherit;font-size:8pt;"> of benefit costs recorded in the Health Care Benefits segment that are included in other insurance liabilities on the consolidated balance sheet and (iii) </span><span style="font-family:inherit;font-size:8pt;"><span>$22 million</span></span><span style="font-family:inherit;font-size:8pt;"> of benefit costs recorded in the Corporate/Other segment that are included in other insurance liabilities on the consolidated balance sheet.</span></div>
CY2017Q4 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Net
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
5000000 USD
CY2017Q4 us-gaap Reinsurance Recoverables On Unpaid Losses Gross
ReinsuranceRecoverablesOnUnpaidLossesGross
0 USD
CY2017Q4 cvs Short Duration Liabilityfor Unpaid Claims Health Care
ShortDurationLiabilityforUnpaidClaimsHealthCare
5000000 USD
CY2018Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
5357000000 USD
CY2018 us-gaap Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense
SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
6594000000 USD
CY2018 us-gaap Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense
SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
-42000000 USD
CY2018 us-gaap Policyholder Benefits And Claims Incurred Health Care
PolicyholderBenefitsAndClaimsIncurredHealthCare
6552000000 USD
CY2018 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
6303000000 USD
CY2018 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
260000000 USD
CY2018 us-gaap Payments For Losses And Loss Adjustment Expense
PaymentsForLossesAndLossAdjustmentExpense
6563000000 USD
CY2018Q4 cvs Premium Deficiency Reserve Liability
PremiumDeficiencyReserveLiability
16000000 USD
CY2018Q4 cvs Short Duration Liabilityfor Unpaid Claims Health Care
ShortDurationLiabilityforUnpaidClaimsHealthCare
6143000000 USD
CY2018Q4 us-gaap Reinsurance Recoverables On Unpaid Losses Gross
ReinsuranceRecoverablesOnUnpaidLossesGross
4000000 USD
CY2018Q4 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Net
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
6147000000 USD
CY2018Q4 cvs Premium Deficiency Reserve Liability
PremiumDeficiencyReserveLiability
16000000 USD
CY2018Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
720000000 USD
CY2017Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
1276000000 USD
CY2018Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
74265000000 USD
CY2017Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
27170000000 USD
CY2018Q4 us-gaap Debt Instrument Unamortized Premium
DebtInstrumentUnamortizedPremium
302000000 USD
CY2017Q4 us-gaap Debt Instrument Unamortized Premium
DebtInstrumentUnamortizedPremium
28000000 USD
CY2018Q4 cvs Debt Instrument Unamortized Discountand Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet
1138000000 USD
CY2017Q4 cvs Debt Instrument Unamortized Discountand Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet
196000000 USD
CY2018Q4 us-gaap Long Term Debt
LongTermDebt
73429000000 USD
CY2018Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
720000000 USD
CY2017Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
1276000000 USD
CY2018Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1265000000 USD
CY2017Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
3545000000 USD
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
71444000000 USD
CY2017Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
22181000000 USD
CY2018Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
1985000000 USD
CY2018Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
5775000000 USD
CY2018Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
10427000000 USD
CY2018Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
4178000000 USD
CY2018Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
8581000000 USD
CY2018Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
43319000000 USD
CY2018Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
74265000000 USD
CY2018Q4 us-gaap Federal Home Loan Bank Advances General Debt Obligations Disclosures Maximum Amount Available
FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable
790000000 USD
CY2018 us-gaap Proceeds From Derivative Instrument Financing Activities
ProceedsFromDerivativeInstrumentFinancingActivities
446000000 USD
CY2018 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
331000000 USD
CY2018Q4 us-gaap Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net
InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
18000000 USD
CY2018Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
2000000000.0 USD
CY2016Q2 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
3500000000 USD
CY2016Q2 us-gaap Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost
GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
-486000000 USD
CY2016Q2 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
50000000 USD
CY2016Q2 cvs Debt Extinguishment Fees
DebtExtinguishmentFees
6000000 USD
CY2016Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-542000000 USD
CY2016Q3 us-gaap Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost
GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
-97000000 USD
CY2016Q3 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
4000000 USD
CY2016Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-101000000 USD
CY2018 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
334000000 USD
CY2017 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
314000000 USD
CY2016 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
295000000 USD
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
1480000000 USD
CY2017 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
2594000000 USD
CY2016 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
2803000000 USD
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
499000000 USD
CY2017 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
464000000 USD
CY2016 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
511000000 USD
CY2017 us-gaap Effective Income Tax Rate Reconciliation Disposition Of Business
EffectiveIncomeTaxRateReconciliationDispositionOfBusiness
0
CY2016 us-gaap Effective Income Tax Rate Reconciliation Disposition Of Business
EffectiveIncomeTaxRateReconciliationDispositionOfBusiness
0
CY2018 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.041
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1979000000 USD
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
3058000000 USD
CY2016 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
3314000000 USD
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
22000000 USD
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-1435000000 USD
CY2016 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
5000000 USD
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
1000000 USD
CY2017 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
14000000 USD
CY2016 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-2000000 USD
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
23000000 USD
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1421000000 USD
CY2016 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
3000000 USD
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2002000000 USD
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1637000000 USD
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3317000000 USD
CY2017 cvs Tax Cutsand Jobs Act Incomplete Accounting Changein Tax Rate Provisional Income Tax Expense Benefit
TaxCutsandJobsActIncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpenseBenefit
-1500000000 USD
CY2018 cvs Tax Cutsand Jobs Act Changein Tax Rate Income Tax Expense Benefit
TaxCutsandJobsActChangeinTaxRateIncomeTaxExpenseBenefit
-100000000 USD
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.277
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.041
CY2016 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.041
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.071
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.183
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0
CY2018 cvs Health Insurer Fee Tax Effect Percent
HealthInsurerFeeTaxEffectPercent
0.022
CY2017 cvs Health Insurer Fee Tax Effect Percent
HealthInsurerFeeTaxEffectPercent
0
CY2016 cvs Health Insurer Fee Tax Effect Percent
HealthInsurerFeeTaxEffectPercent
0.002
CY2018 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
0.895
CY2017 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
0.008
CY2016 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
0
CY2018 us-gaap Effective Income Tax Rate Reconciliation Disposition Of Business
EffectiveIncomeTaxRateReconciliationDispositionOfBusiness
0.050
CY2017 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.018
CY2016 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.009
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
1.424
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.198
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.384
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
277000000 USD
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
291000000 USD
CY2018Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
28000000 USD
CY2017Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
31000000 USD
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
243000000 USD
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
246000000 USD
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
243000000 USD
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
187000000 USD
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Postretirement Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits
130000000 USD
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Postretirement Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits
40000000 USD
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
529000000 USD
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
101000000 USD
CY2018Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
104000000 USD
CY2017Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
93000000 USD
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
467000000 USD
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
0 USD
CY2018Q4 us-gaap Deferred Tax Assets Investments
DeferredTaxAssetsInvestments
11000000 USD
CY2017Q4 us-gaap Deferred Tax Assets Investments
DeferredTaxAssetsInvestments
0 USD
CY2018Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
242000000 USD
CY2017Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
18000000 USD
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
520000000 USD
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
77000000 USD
CY2018Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1754000000 USD
CY2017Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
930000000 USD
CY2018Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
9431000000 USD
CY2017Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
3926000000 USD
CY2018Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
597000000 USD
CY2018Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
9431000000 USD
CY2017Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
3926000000 USD
CY2018Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
7677000000 USD
CY2017Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
2996000000 USD
CY2018Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
529000000 USD
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
520000000 USD
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
344000000 USD
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
307000000 USD
CY2015Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
338000000 USD
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1000000 USD
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
62000000 USD
CY2016 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
68000000 USD
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
324000000 USD
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
32000000 USD
CY2016 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
70000000 USD
CY2018 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
5000000 USD
CY2017 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
28000000 USD
CY2016 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
100000000 USD
CY2018 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
2000000 USD
CY2017 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
10000000 USD
CY2016 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
22000000 USD
CY2018 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
1000000 USD
CY2017 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
19000000 USD
CY2016 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
47000000 USD
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
661000000 USD
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
344000000 USD
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
307000000 USD
CY2018 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
19000000 USD
CY2017 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
11000000 USD
CY2016 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
10000000 USD
CY2018Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
80000000 USD
CY2017Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
34000000 USD
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
280000000 USD
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
234000000 USD
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
222000000 USD
CY2018 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
2000000 shares
CY2018 cvs Stock Issued During Period Employee Stock Purchase Plan Average Purchase Priceof Shares Purchased
StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased
61.40
CY2017 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
55400000 shares
CY2017 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
4400000000 USD
CY2016 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
47500000 shares
CY2016 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
4500000000 USD
CY2018Q4 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.50
CY2018Q4 us-gaap Statutory Accounting Practices Statutory Capital And Surplus Required
StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired
4991000000 USD
CY2018Q4 us-gaap Assets Held By Insurance Regulators
AssetsHeldByInsuranceRegulators
630000000 USD
CY2018Q4 us-gaap Statutory Accounting Practices Statutory Amount Available For Dividend Payments Without Regulatory Approval
StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval
480000000 USD
CY2018Q4 us-gaap Minority Interest
MinorityInterest
318000000 USD
CY2018 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
274000000 USD
CY2017 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
140000000 USD
CY2016 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
53000000 USD
CY2018 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-596000000 USD
CY2017 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
6631000000 USD
CY2016 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
5320000000 USD
CY2018 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
3000000 USD
CY2017 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
24000000 USD
CY2016 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
27000000 USD
CY2018 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2000000 USD
CY2017 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000 USD
CY2016 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2000000 USD
CY2018 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-597000000 USD
CY2017 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
6606000000 USD
CY2016 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
5291000000 USD
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1044000000 shares
CY2017 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1024000000 shares
CY2016 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1079000000 shares
CY2018 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.57
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1044000000 shares
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1020000000 shares
CY2016 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1073000000 shares
CY2018 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2017 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4000000 shares
CY2016 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
6000000 shares
CY2017 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
6.48
CY2016 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
4.93
CY2018 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.57
CY2017 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
6.45
CY2016 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
4.91
CY2019Q1 cvs Numberof Reinsurance Contracts Entered Into
NumberofReinsuranceContractsEnteredInto
2 agreement
CY2018Q4 us-gaap Reinsurance Recoverables On Paid And Unpaid Losses
ReinsuranceRecoverablesOnPaidAndUnpaidLosses
4541000000 USD
CY2018 us-gaap Direct Premiums Earned
DirectPremiumsEarned
8365000000 USD
CY2018 us-gaap Assumed Premiums Earned
AssumedPremiumsEarned
38000000 USD
CY2018 us-gaap Ceded Premiums Earned
CededPremiumsEarned
219000000 USD
CY2018 us-gaap Premiums Earned Net
PremiumsEarnedNet
8184000000 USD
CY2018 us-gaap Policyholder Benefits And Claims Incurred Gross
PolicyholderBenefitsAndClaimsIncurredGross
6773000000 USD
CY2018 us-gaap Reinsurance Effect On Claims And Benefits Incurred Amount Assumed
ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed
32000000 USD
CY2018 us-gaap Reinsurance Effect On Claims And Benefits Incurred Amount Ceded
ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded
211000000 USD
CY2018 us-gaap Policyholder Benefits And Claims Incurred Net
PolicyholderBenefitsAndClaimsIncurredNet
6594000000 USD
CY2018Q4 us-gaap Guarantee Obligations Maximum Exposure
GuaranteeObligationsMaximumExposure
250000000 USD
CY2018Q4 cvs Contractual Obligations To Maintain Levels Of Separate Accounts
ContractualObligationsToMaintainLevelsOfSeparateAccounts
1400000000 USD
CY2018Q4 cvs Guarantor Obligations Numberof Leases
GuarantorObligationsNumberofLeases
85 lease
CY2017Q1 us-gaap Loss Contingency Discounted Amount Of Insurance Related Assessment Liability
LossContingencyDiscountedAmountOfInsuranceRelatedAssessmentLiability
231000000 USD
CY2017Q1 us-gaap Loss Contingency Accrual Insurance Related Assessment Discount Rate
LossContingencyAccrualInsuranceRelatedAssessmentDiscountRate
0.035
CY2016 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
2279000000 USD
CY2017 us-gaap Net Investment Income
NetInvestmentIncome
21000000 USD
CY2018Q4 us-gaap Guaranty Liabilities
GuarantyLiabilities
90000000 USD
CY2015Q3 cvs Loss Contingency Number Of Locations With Subpoena For Documents
LossContingencyNumberOfLocationsWithSubpoenaForDocuments
8 store
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
193919000000 USD
CY2018 us-gaap Net Investment Income
NetInvestmentIncome
660000000 USD
CY2018 us-gaap Revenues
Revenues
194579000000 USD
CY2018 cvs Adjusted Operating Income Loss
AdjustedOperatingIncomeLoss
11261000000 USD
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2718000000 USD
CY2018 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
2123000000 USD
CY2017 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
184765000000 USD
CY2017 us-gaap Net Investment Income
NetInvestmentIncome
21000000 USD
CY2017 us-gaap Revenues
Revenues
184786000000 USD
CY2017 cvs Adjusted Operating Income Loss
AdjustedOperatingIncomeLoss
10825000000 USD
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2479000000 USD
CY2017 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
2049000000 USD
CY2016 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
177526000000 USD
CY2016 us-gaap Net Investment Income
NetInvestmentIncome
20000000 USD
CY2016 us-gaap Revenues
Revenues
177546000000 USD
CY2016 cvs Adjusted Operating Income Loss
AdjustedOperatingIncomeLoss
11421000000 USD
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2475000000 USD
CY2016 us-gaap Net Investment Income
NetInvestmentIncome
20000000 USD
us-gaap Revenues
Revenues
194579000000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
156447000000 USD
us-gaap Policyholder Benefits And Claims Incurred Net
PolicyholderBenefitsAndClaimsIncurredNet
6594000000 USD
us-gaap Operating Expenses
OperatingExpenses
21368000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
4021000000 USD
cvs Adjusted Operating Income Loss
AdjustedOperatingIncomeLoss
11261000000 USD
CY2017 us-gaap Revenues
Revenues
184786000000 USD
CY2017 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
153448000000 USD
CY2017 us-gaap Policyholder Benefits And Claims Incurred Net
PolicyholderBenefitsAndClaimsIncurredNet
2810000000 USD
CY2017 us-gaap Operating Expenses
OperatingExpenses
18809000000 USD
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
9538000000 USD
CY2017 cvs Adjusted Operating Income Loss
AdjustedOperatingIncomeLoss
10825000000 USD
CY2016 us-gaap Revenues
Revenues
177546000000 USD
CY2016 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
146533000000 USD
CY2016 us-gaap Policyholder Benefits And Claims Incurred Net
PolicyholderBenefitsAndClaimsIncurredNet
2179000000 USD
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
998000000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-2563000000 USD
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
9538000000 USD
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
10386000000 USD
CY2018 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1006000000 USD
CY2017 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
817000000 USD
CY2016 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
795000000 USD
CY2018 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
492000000 USD
CY2017 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
65000000 USD
CY2016 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
291000000 USD
CY2016 us-gaap Operating Expenses
OperatingExpenses
18448000000 USD
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
10386000000 USD
CY2016 cvs Adjusted Operating Income Loss
AdjustedOperatingIncomeLoss
11421000000 USD
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
4021000000 USD
CY2018 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
6149000000 USD
CY2017 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
181000000 USD
CY2016 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2018 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
43000000 USD
CY2017 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0 USD
CY2016 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0 USD
CY2018 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
-86000000 USD
CY2017 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
-9000000 USD
CY2016 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 USD
CY2018 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-536000000 USD
CY2017 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
0 USD
CY2016 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
0 USD
CY2018 cvs Store Rationalization Charges
StoreRationalizationCharges
0 USD
CY2017 cvs Store Rationalization Charges
StoreRationalizationCharges
215000000 USD
CY2016 cvs Store Rationalization Charges
StoreRationalizationCharges
34000000 USD
CY2018 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
0 USD
CY2017 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
0 USD
CY2016 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
85000000 USD
CY2018 cvs Adjusted Operating Income Loss
AdjustedOperatingIncomeLoss
11261000000 USD
CY2017 cvs Adjusted Operating Income Loss
AdjustedOperatingIncomeLoss
10825000000 USD
CY2016 cvs Adjusted Operating Income Loss
AdjustedOperatingIncomeLoss
11421000000 USD
CY2018 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-536000000 USD
CY2018Q1 us-gaap Revenues
Revenues
45743000000 USD
CY2018Q2 us-gaap Revenues
Revenues
46922000000 USD
CY2018Q3 us-gaap Revenues
Revenues
47490000000 USD
CY2018Q4 us-gaap Revenues
Revenues
54424000000 USD
CY2018 us-gaap Revenues
Revenues
194579000000 USD
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1996000000 USD
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1373000000 USD
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2574000000 USD
CY2018Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
998000000 USD
CY2018Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-2562000000 USD
CY2018Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
824000000 USD
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
4021000000 USD
CY2018Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
1390000000 USD
CY2018Q4 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-422000000 USD
CY2018 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-596000000 USD
CY2018Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2018 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2018Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.98
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.52
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
1390000000 USD
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
-419000000 USD
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-594000000 USD
CY2018Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.98
CY2018Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-2.52
CY2018Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.36
CY2018Q4 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.37
CY2018 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.57
CY2018Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2018Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2018Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.36
CY2018Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.37
CY2018 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.57
CY2018Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.98
CY2018Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-2.52
CY2018Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.36
CY2018Q4 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.37
CY2018 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.57
CY2018Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2018Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2018Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2018Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2018 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2018Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.98
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.52
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.36
CY2018Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.37
CY2018 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.57
CY2018Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.50
CY2018Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.50
CY2018Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.50
CY2018Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.50
CY2018 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
2.00
CY2017Q1 us-gaap Revenues
Revenues
44520000000 USD
CY2017Q2 us-gaap Revenues
Revenues
45689000000 USD
CY2017Q3 us-gaap Revenues
Revenues
46186000000 USD
CY2017Q4 us-gaap Revenues
Revenues
48391000000 USD
CY2017 us-gaap Revenues
Revenues
184786000000 USD
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1799000000 USD
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
2121000000 USD
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2504000000 USD
CY2017Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
3114000000 USD
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
9538000000 USD
CY2017Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
962000000 USD
CY2017Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
1097000000 USD
CY2017Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
1285000000 USD
CY2017Q4 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
3287000000 USD
CY2017 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
6631000000 USD
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
952000000 USD
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
1098000000 USD
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
1285000000 USD
CY2017Q4 us-gaap Net Income Loss
NetIncomeLoss
3287000000 USD
CY2017 us-gaap Net Income Loss
NetIncomeLoss
6622000000 USD
CY2017Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.93
CY2017Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.07
CY2017Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.26
CY2017Q4 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
3.23
CY2017 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
6.48
CY2017Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.01
CY2017Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2017Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2017Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2017 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.01
CY2017Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.92
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.07
CY2017Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.26
CY2017Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.23
CY2017 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.47
CY2017Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.92
CY2017Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.07
CY2017Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.26
CY2017Q4 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
3.22
CY2017 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
6.45
CY2017Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.01
CY2017Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2017Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2017Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2017 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.01
CY2017Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.92
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.07
CY2017Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.26
CY2017Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.22
CY2017 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.44
CY2017Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.50
CY2017Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.50
CY2017Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.50
CY2017Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.50
CY2017 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
2.00

Files In Submission

Name View Source Status
0000064803-19-000042-index-headers.html Edgar Link pending
0000064803-19-000042-index.html Edgar Link pending
0000064803-19-000042.txt Edgar Link pending
0000064803-19-000042-xbrl.zip Edgar Link pending
cvs-20190807.xsd Edgar Link pending
cvs-20190807_cal.xml Edgar Link unprocessable
cvs-20190807_def.xml Edgar Link unprocessable
cvs-20190807_lab.xml Edgar Link unprocessable
cvs-20190807_pre.xml Edgar Link unprocessable
cvshealtha09.jpg Edgar Link pending
exhibit231.htm Edgar Link pending
exhibit991-item1businessa01.htm Edgar Link pending
exhibit992-exhibit131.htm Edgar Link pending
exhibit993-proforma.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form8-k.htm Edgar Link pending
form8-k_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R107.htm Edgar Link pending
R108.htm Edgar Link pending
R109.htm Edgar Link pending
R11.htm Edgar Link pending
R110.htm Edgar Link pending
R111.htm Edgar Link pending
R112.htm Edgar Link pending
R113.htm Edgar Link pending
R114.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending